PAHC vs DE vs CTVA vs FMC vs CF

For growth investors, Phibro Animal Health Corporation (PAHC) is the stronger pick with 27.

4% revenue growth year-over-year, versus -18. 3% for FMC Corporation (FMC). CF Industries Holdings, Inc. (CF) offers the better valuation at 13. 2x trailing P/E (8. 4x forward), making it the more compelling value choice. Analysts rate Phibro Animal Health Corporation (PAHC) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, CF Industries Holdings, Inc.

(CF) is the cheapest at 13. 2x versus Corteva, Inc. at 49. 4x. On forward P/E, FMC Corporation is actually cheaper at 7. 7x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: CF Industries Holdings, Inc. wins at 0. 19x versus Deere & Company's 1. 99x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

Over the past 5 years, CF Industries Holdings, Inc.

(CF) delivered a total return of +130. 9%, compared to -80. 2% for FMC Corporation (FMC). Over 10 years, the gap is even starker: DE returned +671. 0% versus FMC's -26. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), CF Industries Holdings, Inc.

(CF) is the lower-risk stock at -0. 62β versus FMC Corporation's 1. 63β — meaning FMC is approximately -361% more volatile than CF relative to the S&P 500. On balance sheet safety, Corteva, Inc. (CTVA) carries a lower debt/equity ratio of 11% versus 3% for Phibro Animal Health Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Phibro Animal Health Corporation (PAHC) is pulling ahead at 27.

4% versus -18. 3% for FMC Corporation (FMC). On earnings-per-share growth, the picture is similar: Phibro Animal Health Corporation grew EPS 1883% year-over-year, compared to -757. 4% for FMC Corporation. Over a 3-year CAGR, PAHC leads at 11. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

CF Industries Holdings, Inc.

(CF) is the more profitable company, earning 20. 5% net margin versus -64. 6% for FMC Corporation — meaning it keeps 20. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CF leads at 33. 4% versus -54. 4% for FMC. At the gross margin level — before operating expenses — CTVA leads at 43. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, CF Industries Holdings, Inc. (CF) is the more undervalued stock at a PEG of 0. 19x versus Deere & Company's 1. 99x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, FMC Corporation (FMC) trades at 7. 7x forward P/E versus 32. 5x for Deere & Company — 24. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DE: 17. 3% to $680. 54.

All stocks in this comparison pay dividends.

FMC Corporation (FMC) offers the highest yield at 17. 0%, versus 0. 9% for Corteva, Inc. (CTVA).

For long-horizon retirement investors, CF Industries Holdings, Inc.

(CF) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 62), 1. 7% yield, +338. 1% 10Y return). FMC Corporation (FMC) carries a higher beta of 1. 63 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CF: +338. 1%, FMC: -26. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (PAHC (Healthcare) and DE (Industrials) and CTVA (Basic Materials) and FMC (Basic Materials) and CF (Basic Materials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: PAHC is a small-cap high-growth stock; DE is a mid-cap quality compounder stock; CTVA is a mid-cap quality compounder stock; FMC is a small-cap income-oriented stock; CF is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.